Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib

Detalles Bibliográficos
Autores principales: Moore, Angela Yen, Cepica, Tyler, Maberry, Samanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014316/
https://www.ncbi.nlm.nih.gov/pubmed/35445147
http://dx.doi.org/10.1016/j.jdcr.2022.02.025
_version_ 1784688181413675008
author Moore, Angela Yen
Cepica, Tyler
Maberry, Samanna
author_facet Moore, Angela Yen
Cepica, Tyler
Maberry, Samanna
author_sort Moore, Angela Yen
collection PubMed
description
format Online
Article
Text
id pubmed-9014316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90143162022-04-19 Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib Moore, Angela Yen Cepica, Tyler Maberry, Samanna JAAD Case Rep Case Report Elsevier 2022-03-10 /pmc/articles/PMC9014316/ /pubmed/35445147 http://dx.doi.org/10.1016/j.jdcr.2022.02.025 Text en © 2022 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Moore, Angela Yen
Cepica, Tyler
Maberry, Samanna
Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
title Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
title_full Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
title_fullStr Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
title_full_unstemmed Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
title_short Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
title_sort amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014316/
https://www.ncbi.nlm.nih.gov/pubmed/35445147
http://dx.doi.org/10.1016/j.jdcr.2022.02.025
work_keys_str_mv AT mooreangelayen ameliorationofunstablevitiligoandnormalizationofthryroglobulinantibodieswithoraltofacitinib
AT cepicatyler ameliorationofunstablevitiligoandnormalizationofthryroglobulinantibodieswithoraltofacitinib
AT maberrysamanna ameliorationofunstablevitiligoandnormalizationofthryroglobulinantibodieswithoraltofacitinib

Ejemplares similares